Democratising Healthcare Technology: The Role and Challenges of Participatory Design in Healthcare

September 27, 2024 @ 12:00 pm 1:00 pm

Register for this free teams webinar here: https://futurebloodtesting.org/event/2024-09-27 Abstract: In this talk, Dr Stephen Lindsay will delve into the fundamental principles of participatory design, focusing on its role in democratizing the development of healthcare technologies. He will begin by exploring the core definition of participatory design, emphasizing its potential to empower users by involving them directly in the creation process. He will then contrast this approach with current Patient and Public Involvement and Engagement (PPIE) practices in the UK, highlighting how participatory design extends beyond consultation to share decision-making in design. The talk will also examine the specific challenges of applying participatory design in healthcare, navigating ethical considerations, ensuring inclusivity, and managing the complexities of working with vulnerable populations. Through case studies from his own work, he will demonstrate how participatory design can overcome these challenges, leading to more inclusive, effective, and ethically sound healthcare solutions, and offering a critical perspective on the limitations of traditional PPIE approaches. Bio: Dr Stephen Lindsay is a Lecturer in Digital Healthcare and HCI at Glasgow University. His research is cantered on participatory design, particularly with marginalized groups such as older adults, people living with dementia, and individuals with brain injuries. Dr Lindsay believes that involving these under-heard voices in healthcare technology design not only fosters more ethical practices but also drives innovation. His work has addressed diverse areas, including designing digital tools for older adults, supporting less-literate diabetes patients in rural Pakistan, and creating technologies that genuinely reflect patients’ needs and experiences. Through this approach, Dr Lindsay contributes to the development of digital health tools that are both ethically sound and practically effective, grounded in the lived experiences of those they aim to serve. This webinar is part of the 2024 Future Blood Testing Network+ webinar series. This series will feature a diverse range of speakers who are working in the areas of future blood testing and diagnostics.

Details

Organiser

Online

Multicorder – Enabling the Future of POC Diagnostics and Screening

Register for this free teams webinar here: https://futurebloodtesting.org/event/2024-09-12

Abstract:

Precision metabolomics and quantification for cost-effective rapid diagnosis of disease are the key goals in personalized medicine and point-of-care testing. At present, patients are subjected to multiple test procedures requiring large laboratory equipment. Here, we present a versatile single complementary metal–oxide–semiconductor chip forming a platform to address personalized needs through on-chip multimodal optical and electrochemical detection that will reduce the number of tests that patients must take. The chip integrates interleaved sensing subsystems for quadruple-mode colorimetric, chemiluminescent, surface plasmon resonance, and hydrogen ion measurements. These subsystems include a photodiode array and a single photon avalanche diode array and an array of ion sensitive field-effect transistors. The sensor arrays are distributed uniformly over an active area on the chip surface in a scalable and modular design. Bio-functionalization of the physical sensors yields a highly selective simultaneous multiple-assay platform in a disposable format. We have demonstrated its versatile capabilities through various applications such as CVD, prostate cancer diagnosis and bleeding disorders monitoring.

Bio:

Dr Chunxiao Hu is a Lecturer in Biomedical Engineering at the University of Glasgow. His research focuses on developing miniaturised portable microsystem platforms by using advanced technologies such as microfluidics, nanofabrication, surface functionalization for biomedical applications. Current projects include Highly integrated chemical sensors (electrical and optical) for multiple detection of biomarkers for early cancer diagnostics; CMOS based ISFET for fast antimicrobial susceptibility testing; Wearable biosensor for continuous monitoring of stroke; Microfluidic device for neurodegenerative diseases; Microfluidic device for electrophysiological analysis of drug uptake in nematodes.

This webinar is part of the Future Blood Testing Network+ Webinar Series. This series will feature a diverse range of speakers who are working in the areas of future blood testing and diagnostics.

25/04/2024- Funding Opportunity: Technologies to enable independence for people living with dementia

The Engineering and Physical Sciences Research Council (EPSRC), in collaboration with the National Institute for Health and Care Research (NIHR), is calling for applications to develop a NetworkPlus focused on the use and development of novel tools and technologies that help people with dementia live independently.

This initiative is designed to support NetworkPlus grants that develop technologies to help people transform their care and health to become more independent at home. Networks should explore and identify the pathways and barriers to implementing these tools and technologies within the health and care system. They should also examine how technologies can be integrated into the home and coordinate care with carers and health and social care professionals, where appropriate

The role of the NetworkPlus is to nurture research ideas among its members and facilitate the transfer of knowledge to a broader community. Networks are encouraged to collaborate with a range of project partners.

🔗 To apply for this funding opportunity, visit: Technologies to enable independence for people living with dementia – UKRI

Key Dates:

  • Publication Date: 25 April 2024
  • Opening Date: 16 May 2024, 9:00am UK time
  • Closing Date: 10 September 2024, 4:00pm UK time

Eligibility and Funding Details:

  • Must be based at a UK research organisation eligible for EPSRC funding.
  • The full economic cost (FEC) of projects can be up to £2,000,000.
  • EPSRC and NIHR will fund 80% of the FEC.
  • Project duration: Up to 36 months.

To be successful, proposals need to demonstrate a clear vision, an understanding of the wider context, and the added value arising from the network. Networks should set their research focus within the UK health and social care system, with a particular interest in how tools and technologies could be realistically implemented into the current system.

Don’t miss out on this opportunity!
Apply by 10 September 2024, 4:00pm UK time.

Cyber Security Attack Impacts NHS Blood and Transplant

The recent cyber attack on Synnovis has made front-page news over the last few days due to its significant impact on pathology services at London hospitals and the subsequent increased requests for blood donors. The Future Blood Testing Network Plus has consulted researchers, Prof Carsten Maple and Dr Gregory Epiphaniou, from  the Secure Cyber Systems Research Group at WMG, University of Warwick, to gain insight into why this attack has severely affected pathology services.

A recent cyber attack has caused significant challenges for NHS Blood and Transplant leading to the organisation issuing an urgent appeal for blood donations. 

It is becoming commonplace to read or hear about a new cyber attack in the public or professional media. The UK has seen a sharp rise in severe cyber attacks, particularly those aimed at extorting money from the victim – ransomware attacks. According to the National Cyber Security Centre (NCSC), the number of ransomware attacks surged by over 27% in the past year. The NCSC received 2,005 incident reports in 2023, a 64% increase from the previous year, with 371 of these being severe enough to involve their Incident Management team (NCSC Annual Report, 2023).

Ransomware attacks have impacted a broad spectrum of sectors, from healthcare to cultural institutions such as the British Library attack in October last year.

The rise in ransomware is fuelled by a criminal ecosystem where cybercrime services can be easily procured. This allows attackers to execute ransomware attacks effectively. These criminals typically demand payments in cryptocurrencies including Bitcoin, which are difficult to trace. Even if the ransom is paid, victims may not regain access to all their files (Joint Committee on National Security Strategy, 2023).

The attack early this week on Synnovis, a pathology service provider for major London hospitals, disrupted the ability to match patient blood types. This led to an urgent appeal for O-type blood donors. O Positive blood can be given to anyone with a positive blood type, benefiting three-quarters of the population, while O Negative, known as the universal blood type, can be given to any patient (BBC News, 2024a).

The suspected perpetrators of the attack are the Qilin ransomware cyber gang, a Russian group recognised for operating a ransomware-as-a-service model over the last two years. In this instance, the attackers likely accessed Synnovis’ systems by sending phishing emails. Then, they will then have used IAX Active Directory security to increase their privilege level and propagate throughout the network. To coerce victims into paying the ransom, the Qilin gang uses double extortion, encrypting data and exfiltrating private information. The first extortion concerns requiring a payment in exchange for the decryption keys so that the victim can recover information that is encrypted, and the second requires payment to prevent release of the private information.  This latest incident is reflective of a growing pattern of attacks on the healthcare industry, with similar attacks affecting SYNLAB Italia in April 2024 and the NHS Dumfries & Galloway in March 2024.

The NHS has announced that recovery from the attack could take months, and given recent attacks that is likely to be the minimum disruption.  The impact of cyber attacks can be profound and long-lasting. The cyber attack on the British Library led to a major technology outage, causing substantial damage. This has required the installation of a new computing infrastructure, and despite efforts to restore services, disruptions persist. In November, the attackers released some of the library’s data onto the dark web, including personal user information (British Library, 2024). It is unknown which information has been captured in the Synnovis breach, but it is likely that at least some of that will be donor personal information and will be released in some way – the attackers wanting to show they will make good on their threats as a message to future victims. It is likely that as with the British Library, Synnovis and the NHS will work with NCSC to understand and recover from the attack. Despite the escalating threat, less than half of organisations have a formal ransomware plan – indeed it has recently been reported that 8% of victims have resorted to paying ransom demands (Thales, 2024).

The increase in cyber attacks underscores the urgent need for robust cybersecurity measures. Organisations need to develop comprehensive plans to address ransomware threats and invest in resilient defenses. Continuous research and investment in cybersecurity are essential to protect critical national infrastructure, maintain public trust, and ensure national security. Addressing these challenges head-on is crucial for the UK’s resilience against the evolving cyber threat landscape (Craig, 2018; Royal Society, 2022).

Authors

Prof Carsten Maple is Director of the NCSC-EPSRC Academic Centre of Excellence in Cyber Security Research and Professor of Cyber Systems Engineering at the University of Warwick. He is also a co-investigator of the PETRAS National Centre of Excellence for IoT Systems Cybersecurity, is the Research Innovation Director at EDGE-AI, the National Edge Artificial Intelligence Hub, and is a Fellow of the Alan Turing Institute.

Dr. Gregory Epiphaniou is an Associate Professor of Security Engineering at the University of Warwick, focusing on bid support, applied research, and publications. His research includes threat source characterisation and wireless communications, mainly on crypto-key generation through V-V channels. He has led and contributed to research projects worth over £20M, funded by EPSRC, IUK, and local authorities. He holds industry certifications in Information Security and has collaborated with the UK MoD. He is a subject matter expert at the Chartered Institute for Securities and Investments, a technical committee member for scientific conferences, and acted as a key member in forming the UK Cybersecurity Council WS5.

References

BBC News, 2024a. O-type blood donors needed after London cyber-attack. [online] Available at: https://www.bbc.co.uk/news/articles/c2eeg9gygyno.

British Library, 2024. British Library cyber incident review. [online] Available at: https://www.bl.uk/home/british-library-cyber-incident-review-8-march-2024.pdf.

Craig, A., 2018. Effective cyber security research can support the resilience of our digital and physical infrastructures.

Joint Committee on National Security Strategy, 2023. A hostage to fortune: ransomware and UK national security. [online] Available at: https://publications.parliament.uk/pa/jt5804/jtselect/jtnatsec/194/report.html.

NCSC Annual Review, 2023. https://www.ncsc.gov.uk/collection/annual-review-2023

Royal Society, 2022. Continuous investment in cybersecurity to counter evolving risks.

Thales, 2024. Thales data threat report reveals rise in ransomware attacks, as compliance failings leave businesses vulnerable to breaches. [online] Available at: https://www.thalesgroup.com/en/worldwide/security/press_release/2024-thales-data-threat-report-reveals-rise-ransomware-attacks.

Photonic Biosensing of Alzheimer’s Disease Biomarkers

July 5, 2024 @ 12:00 pm 1:00 pm

Register for this free teams webinar here: https://futurebloodtesting.org/event/2024-07-05 Abstract: A major issue facing the diagnosis of neurodegenerative disease is the availability of an accessible, scalable, and highly sensitive technology. Compelling evidence now suggests that the abundance of blood-based dementia biomarkers, including ß-amyloid (Aß) and tau, and their ratios, change considerably before clinical symptoms arise. Assessing these parameters via a straightforward blood test could facilitate early-stage diagnosis, recruitment of patients into clinical trials, and open a platform for at-home treatment monitoring. Current technologies for biomarker analysis are resource-intensive, rely on cerebrospinal fluid extraction, and are not widely adopted. Here, we demonstrate the detection of blood-based biomarkers using a next-generation, label-free photonic biosensor based on the principle of chirped guided mode resonance (GMR) spectroscopy. Our handheld GMR device is a low-cost optical biosensor suitable for the real-time, sensitive and parallel detection of dementia biomarkers. The technology utilizes wavelength scale grating structures to excite a standing wave that is sensitive to refractive index changes on the sensor surface. When target biomarkers bind to antibodies on the sensor surface, a refractive index change gives rise to a detectable shift in resonance wavelength. The chirped element of the GMR translates spectral information into spatial position, allowing biomarker binding to be detected by imaging the spatial position of the optical resonance on a simple camera detector. Our label-free technology outperforms competing modalities including surface plasmon approaches, has demonstrable sensitivity to pg/mL concentrations of low molecular weight protein biomarkers, offers a wide dynamic range, is mechanically and thermally stable, enables the real-time detection of at least eight biomarkers in parallel, and corrects for non-specific binding. By applying our biosensing approach to the detection of dementia biomarkers, we have demonstrated the real-time and quantitative detection of Aß in laboratory analytes, paving the way for further developments towards a blood test technology to support disease diagnosis, at-home treatment monitoring, and the democratization of testing. Bio: Dr Steven Quinn obtained an MPhys in Physics from the University of St. Andrews (2009) and an MSc in Radiation, Oncology and Biology from the University of Oxford (2010). After his PhD (St Andrews, 2013) and a postdoctoral position at the University of Glasgow (2013-2016), he took up a Lindemann Trust Fellowship at the Massachusetts Institute of Technology (2016-2017). In 2017, he was appointed to a Lectureship at the University of York and was awarded an Alzheimer’s Research UK Fellowship in 2019. Steven is now a Senior Lecturer, and his group uses a variety of analytical, biosensing and single-molecule techniques to detect and interrogate the structure and dynamics of biomolecules implicated in dementia. This webinar is part of the Future Blood Testing Network+ Webinar Series. This series will feature a diverse range of speakers who are working in the areas of future blood testing and diagnostics.

Details

Organiser

Online

Blood testing miniaturisation – opportunities, trends and challenges. Dr Al Edwards (University of Southampton)

May 17, 2024 @ 12:00 pm 1:00 pm

Register for this free teams webinar here: https://futurebloodtesting.org/event/2024-05-17 Abstract: Although the need for better diagnostics, especially point-of-care testing, is clear, the uptake of novel technology lags a long way behind demonstration and research papers. Using several case studies from my own research, alongside insight from current state-of-the art notably in diagnostics for microbiology and infection, I will outline the technological basis for bioassay miniaturisation (i.e. tiny blood tests) and discuss the diagnostics innovation pathway. Examples will include a review of >10 years developing microfluidic quantitative multiplex immunoassays that can measure multiple biomarkers in blood, as well as our latest developments in measuring platelet cell function directly in blood. Bio: With a background in fundamental immunology combined with expertise in biochemical engineering, Al Edwards is an interdisciplinary researcher focussed on solving current and future healthcare challenges using an engineering science approach that combines a range of fields from biology, biochemistry, chemistry and physics. He works at the interface between academic technology discovery and industrial development and have experience of both fundamental research and the commercialisation of new technology. The two main challenges he currently work on are the development of affordable microfluidic technology for clinical diagnostics and microbiology, and the engineering science of complex biologic therapeutics such as vaccines. This webinar is part of the Future Blood Testing Network+ Webinar Series. This series will feature a diverse range of speakers who are working in the areas of future blood testing and diagnostics.

Details

Organiser

Online

“Digitally enabled blood testing for healthcare” mini-track was successfully organised at the 57th Hawaii International Conference on System Sciences (HICSS) in Honolulu on Jan 4th, 2024

The mini-track was co-chaired by Prof. Weizi Li (University of Reading, UK), Prof. Kendall Ho (The University of British Columbia Columbia, Canada), Dr. Hector Zenil (Oxford Immune Algorithmics, UK), and Dr. Dionne Tannetta (Royal Berkshire NHS Foundation Trust, UK)

Dr. Tannetta’s talk showed how the Virtual Ward initiative in the UK is taking off and how it came about from the lessons learned from the Covid-19 pandemic where 131 patients remained at home closely monitored remotely under a very successful triaging clinical pathway. On the other hand, Prof. Li explained how an early-stage project to incorporate Generative AI in an arthritis triaging pathway, has led to an increase of accurate referral from primary to secondary care. Both projects show the promise and the future of AI and remote digital care in healthcare and medicine.

The Hawaii International Conference on System Sciences or 𝘏𝘐𝘊𝘊𝘚, is organised by the University of Hawai‘i – Shidler College of Business. It is known to be the longest-standing working scientific conference in Information Technology Management. Since 1968, 𝘏𝘐𝘊𝘊𝘚 has provided a highly interactive working environment for top scholars from academia and the industry from over 60 countries to exchange ideas in various areas of information, computer, and system sciences.

HICSS ranks second in citation ranking among 18 Information Systems (IS) conferences, third in value to the MIS field among 13 Management Information Systems (MIS) conferences, and second in conference rating among 11 IS conferences – more information can be found on the conference website: https://hicss.hawaii.edu.

The Future of Healthcare: Remote Blood Testing, Monitoring & AI

Registration Link: https://www.store.reading.ac.uk/conferences-and-events/henley-business-school/workshops/the-future-of-healthcare-remote-blood-testing-monitoring-ai

Formal Event Flyer: https://futurebloodtesting.org/fbtn2023/eventflyer

Description:

At the Future Blood Testing Network Plus, we are aiming to build a multi-disciplinary community to develop digital health technologies for remote, rapid, affordable and inclusive monitoring and personalised analytics. This two day workshop will feature speakers to discuss the future of healthcare, remote blood testing, monitoring and artificial intelligence (AI).

This event will take place at Leonardo Hotel Southampton (Formerly Jurys Inn). Both days will include lunch and coffee breaks, with day 1 also including a drinks reception with dinner.

NB: Due to venue policies on final numbers we cannot guarantee that we can cater to all dietary requirements after the 12th October. 

Event Costs

  • £30 – Physical Day Attendance (Includes lunch on both days, and dinner and drinks on day 1)
  • £50 – Accommodation (per night – Bed and Breakfast available on the 6th and 7th November)

Draft Agenda

Day 1 – 7th November

  • 10:00-10:30: Coffee & Registration
  • 10:30-12:00: Session 1: Landscape of Future Blood Testing – Session Chair: Dr Samantha Pearman-Kanza (University of Southampton)
    • 10:30-11:00: Future Blood Testing Network+ Overview and RecapProfessor Weizi (Vicky) Li (University of Reading)
    • 11:00-11:30: Remote Testing & AI – What’s Coming NextMr Frank Khan Sullivan (Enhanced Fertility)
    • 11:30-12:00: Landscape of Future blood testing in healthcare practice – Professor Dimitris Grammatopoulos (University of Warwick)
  • 12:00-13:00: Lunch & Photo session
  • 13:00-15:00: Session 2: Network Funded Projects  – Session Chair: Prof Weizi (Vicky) Li (University of Reading)
    • 13:00-13:30: Multi-modal deep learning approaches for identification of prognostic and diagnostic biomarkersDr Heba Sailem (Kings College London)
    • 13:30-14:00: FERRIQ: AI-Driven mapping of disease trajectories of patients with genetic iron overload to inform development of clinical decision support systemsDr Fayyaz Minhas & Professor Dimitris Grammatopoulos (University of Warwick)
    • 14:00-14:15: Development of an implantable device for continuous monitoring of blood biomarkersDr Chenyang He (University of Nottingham)
    • 14:15-14:30: Blood microfluidics for point of care diagnosticsProfessor Stavroula Balabani (UCL)
    • 14:30-14:45: Raman spectroscopy for remote blood testing – Dr Donna Arnold (University of Kent)
    • 14:45-15:00: Wearable Otological Measurement of Blood Analytes (WOMBA) – Dr Peter J. Christopher (University of Nottingham)
  • 15:00-15:15: Coffee Break
  • 15:15-17:15: Session 3: Adoption & Design for the Future of Digital Healthcare & Diagnostics: Design, data, NHS adoption and commercialisation
    • 15:15-15:30: Information Design in medical testingProfessor Sue Walker (University of Reading)
    • 15:30-17:15: Round Table (facilitated by Al, Sue, Mamta, Age)
      • Design: Professor Sue Walker (University of Reading)
      • Data: Professor Age Chapman (University of Southampton)
      • NHS adoption: Dr Mamta Bajre (Oxford Academic Health Science Network)
      • Commercialisation: Associate Professor Alexander Edwards (University of Southampton)
  • 17:10-17:30: Wrap Up
  • 17:30-19:00: Drinks Reception & Networking
  • 19:00: Conference Dinner

Day 2 – 8th November

  • 09:30-09:55: Coffee
  • 09:55-10:00: Welcome BackProfessor Weizi (Vicky) Li (University of Reading)
  • 10:00-12:30: Session 4: Future Blood Testing Research – Chair: Dr Mark Elliott (University of Warwick)
    • 10:00-10:30: Translating blood tests from the Academic Lab into the Clinical Setting – a Case StudyDr Martin Peacock (Zimmer and Peacock Ltd)
    • 10:30-11:00: An immune score based on longitudinal blood testingDr Hector Zenil (Oxford Immune Algorithmics)
    • 11:00-11:30: Coffee Break
    • 11:30-12:00: Detection of drugs and biomarkers in healthcare using optical fibre sensorsProfessor Serhiy Korposh (University of Nottingham)
    • 12:00-12:30: Squishing Biology to Advance Healthcare: A Journey from Saliva to Blood
      Dr Robert Barker (University of Kent)
  • 12:30-13:30: Lunch

13-14/09/2022 – Future Blood Testing: Challenges & Opportunities

Eventbrite Link: https://fbtn-workshop-sept2022.eventbrite.co.uk 

Formal Event Flyer: https://futurebloodtesting.org/wp-content/uploads/2022/09/ReadingFlyerFinalVersion.pdf

Description:
At the Future Blood Testing Network Plus, we are aiming to build a multi-disciplinary community to develop digital health technologies for remote, rapid, affordable and inclusive monitoring and personalised analytics. This two day workshop will feature speakers to discuss the challenges and opportunities associated with this. We will also be launching our second funding call for both our technical landscape report, and for our pilot projects. This event will run as a hybrid event, the physical event will take place at the University of Reading in the Park House Building. Both days will include lunch and coffee breaks, with Day 1 also including a drinks reception with canapés, and dinner. Virtual attendees will be able to join us via Zoom.

NB: Due to venue policies on final numbers we cannot guarantee that we can cater to all dietary requirements after the 30th August. 

Posters & Pitches:
There will be an opportunity to submit a short pitch to present at this 2 day event. Please fill in our Pitch Form to submit a poster or pitch presentation.

  • Pitches will be one minute long with 1-2 slides. Delegates will introduce their expertise and collaborations they are looking for to develop a collaborative innovation project

NB: Pitch Presentations can take place virtually or physically. If you are planning on attending physically to give a pitch, you MUST have registered via our Eventbrite. You need to be registered in order to have your submission accepted. 

The deadline for submissions via this form is the 13th September (however we will email you as soon as we get your submission to tell you if you have been accepted or not).

Electronic copies of pitches should be sent to Dr Samantha Kanza s.kanza@reading.ac.uk by the 13th September. 

Agenda:

Day 1 – 13th September – Park House Building. The main workshop, refreshments, and the conference dinner will take place in the Meadow Suite, and the Drinks Reception will take place in Blandfords.

Time Session/Talk
09:30-10:00 Coffee & Registration
10:00-10:15 Future Blood Testing Network+ Overview
Prof Weizi (Vicky) Li (University of Reading)
Session 1: Chaired by Dr Robert Barker (University of Kent)
10:15-11:00 Transforming the UK’s diagnostics agenda after COVID-19 and grand challenges – Future Blood Testing Landscape report
Prof Dimitris Grammatopoulos (University Hospitals Coventry & Warwickshire, University of Warwick)
11:00-11:45 Measuring platelet function: new strategies for precision medicine to prevent thrombosis
Prof Jon Gibbins (University of Reading)
11:45-12:15 Coffee Break, Networking – There will also be a Group Photo
12:15-13:00 Lab services for a Web 3.0 world: how the next transformation will enable the democratisation of blood testing to have access and control of our own health
Dr Hector Zenil (University of Oxford & Oxford Immune Algorithmics)
13:00-14:00 Lunch
Session 2: Chaired by Prof Jeremy Frey (University of Southampton)
14:00-14:30 Remote blood monitoring for cancer patients- a preliminary landscape analysis
Beth Harvey (University of Reading)
14:30-15:00 Improving triaging from primary care into secondary care using heterogeneous data-driven hybrid machine learning: A real-world case study of decision support system using blood test & GP referral letters
Bing Wang and Prof Weizi (Vicky) Li (University of Reading)
15:00-15:45 Unmet Clinical Needs and Case Studies in Blood Testing
Prof Bryant Lin and Dr. Kevin Chang (Stanford University)
15:45-16:00 Coffee Break & Networking
Session 3: Chaired by Dr Samantha Kanza (University of Reading)
16:00-16:30 Collaborative Innovation Project funding launch
Dr Samantha Kanza (University of Reading)
16:30-17:00 One-minute pitch
Delegates introduce their expertise and collaborations they are looking for to develop a collaborative innovation project
17:00-19:00 Drinks Reception & Networking
19:00-20:00 Dinner & Networking

Day 2 – 14th September – Park House Building. The main workshop, and refreshments will take place in the Meadow Suite.

Time Session/Talk
09:30-10:00 Coffee & Registration
10:00-10:05 Welcome back
Prof Weizi (Vicky) Li (University of Reading)
Session 4: Chaired by Prof Serhiy Korposh (University of Nottingham)
10:05-10:35 Digital Solutions and Remote Monitoring in Real World Clinics
Dr Antoni Chan (Royal Berkshire NHS Foundation Trust)
10:35-11:05 ”Tiny Test Tubes” for affordable microfluidic blood measurements at the point of need
Dr Alexander Edwards (University of Reading)
11:05-11:20 Coffee Break & Networking
Session 5: Chaired by Claire Read (Healthcare Writer)
11:20-13:00 Panel discussion:
– Grand challenges of future blood testing
– Can NHS make use of remote blood monitoring and lessons learned from COVID testing
– Fake it till you make it? How do we achieve the future of blood testing without becoming the next Theranos?
Panel: Prof Neil Anderson, Dr Keith Arundale, Dr Antoni Chan, Dr Alexander Edwards, Prof Dimitris Grammatopoulos, Julie Hart
13:00-14:00 Lunch
Session 6: Chaired by Dr Mark Elliott (University of Warwick)
14:00-14:45 Artificial intelligence for identification of blood cells
Prof Huiyu Zhou (University of Leicester)
14:45-15:15 Precision Health and AI: improving health for everyone
Arjun Panesar (DDM Health)
15:15-15:30 Coffee Break & Networking
Session 7: Chaired by Dr Samantha Kanza (University of Reading)
15:30-16:15 One-minute pitch
Delegates introduce their expertise and collaborations they are looking for to develop a collaborative innovation project. Groups developed from the event present their concept and proposal outline 
16:15-16:30 Closing Remarks
Prof Weizi (Vicky) Li & Dr Samantha Kanza (University of Reading)

 

03/02/2021 – Future Blood Testing Network+ Landscape Report Funding Town Meeting

February 3, 2022 @ 3:00 pm 4:30 pm

Eventbrite Link: https://futurebloodtechtownmeeting-030222.eventbrite.co.uk  Description: This is the virtual launch event for the Future Blood Testing Network! The Future Blood Testing Network+ is a new Network funded by EPSRC. We are aiming to build a multi-disciplinary community to develop digital health technologies for remote, rapid, affordable and inclusive monitoring and personalised analytics. 

Our first funding call will be to fund three projects to produce content for our landscape report that will provide the roadmap of developing new digital health systems to support real-time blood monitoring, self management and timely intervention in community health and care. Each report will include a systematic review of the key literature and involve interviewing key stakeholders to establish the current picture and identify the gaps.

The report will have three main streams:

  • Future blood testing in healthcare practice: For example but not limited to: clinical needs, early adopters, challenges and opportunities, regulations, buy-in, user acceptance, existing and potential use cases for healthcare professionals and hospitals, patients, laboratories etc
  • Remote blood processing and monitoring: For example but not limited to: sensing, imaging, point of care blood testing, portable and affordable , non-invasive, and other promising technologies for detecting blood biomarkers outside clinical settings
  • ICT, Data, Analytics and AI: For example but not limited to: challenges and opportunities in entire data lifecycle from point of testing/monitoring, to linking in with NHS Systems and other healthcare Systems including aspects of ICT infrastructure, data security, trust, ethics, data quality, provenance etc, and the AI technologies and analytics methods required to create the personalised analytics in patient pathways

Register for our town meeting to find out how to apply to this funding call! Please also fill out our expression of interest if you haven’t done so already: https://forms.office.com/r/Y3uCf0CqR7

Agenda:

Time Talk Speaker
15:00-15:05 Welcome Dr Samantha Kanza (Network Coordinator)
15:05-15:15 Network Introduction Dr Weizi Li (Network Director)
15:15-15:30 Introducing the Funding Call Dr Samantha Kanza (Network Coordinator)
15:30-16:25 Panel Q+A  Dr Weizi LiDr Rob Barker, Dr Mark Elliott, Prof Jeremy Frey, Dr Serhiy Korposh, Dr Samantha Kanza
16:25-16:30 Wrap up Dr Weizi Li (Network Director)

Details

Organiser

Online